Risk and prognosis of bacteremia among individuals with and without end-stage renal disease: A Danish, population-based cohort study

BMC Infectious Diseases

Volumn 15, Issue 1, 2015, Pages

  Nielsen, Lise H ^a   Jensen Fangel, Søren ^a   Benfield, Thomas ^b,c   Skov, Robert ^d   Jespersen, Bente ^a   Larsen, Anders R ^d   Østergaard, Lars ^a   Støvring, Henrik ^e   Schønheyder, Henrik C ^f   Søgaard, Ole S ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d STATENS SERUM INSTITUT   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

^f AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bacteremia; Dialysis; End stage renal disease; Staphylococcus aureus

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CULTURE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DANISH CITIZEN; END STAGE RENAL DISEASE; FATALITY; FEMALE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INFECTION RATE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; STAPHYLOCOCCAL BACTEREMIA; ADVERSE EFFECTS; BACTEREMIA; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; DENMARK; ISOLATION AND PURIFICATION; REGISTER; RENAL REPLACEMENT THERAPY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

ADULT; AGED; BACTEREMIA; CASE-CONTROL STUDIES; COHORT STUDIES; DENMARK; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; REGISTRIES; RENAL DIALYSIS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84923902308     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-014-0740-8     Document Type: Article

References (26)

1. Lentino JR, Baddour LM, Wray M, Wong ES, Yu VL. Staphylococcus aureus and other bacteremias in hemodialysis patients: antibiotic therapy and surgical removal of access site. Infection. 2000;28:355-60.
2. Laupland KB, Church DL, Mucenski M, Sutherland LR, Davies HD. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis. 2003;187:1452-9.
3. Stefan G, Stancu S, Capusa C, Ailioaie OR, Mircescu G. Catheter-related infections in chronic hemodialysis: a clinical and economic perspective. Int Urol Nephrol. 2013;45:817-23.
4. Fitzgerald SF, O'Gorman J, Morris-Downes MM, Crowley RK, Donlon S, Bajwa R, et al. A 12-year review of Staphylococcus aureus bloodstream infections in haemodialysis patients: more work to be done. J Hosp Infect. 2011;79:218-21.
5. Lemaire X, Morena M, Leray-Moragues H, Henriet-Viprey D, Chenine L, Defez-Fougeron C, et al. Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for hemodialysis. Blood Purif. 2009;28:21-8.
6. Silva Jr M, Marra AR, Pereira CA, Medina-Pestana JO, Camargo LF. Bloodstream infection after kidney transplantation: epidemiology, microbiology, associated risk factors, and outcome. Transplantation. 2010;90:581-7.
7. Peacock SJ, Mandal S, Bowler IC. Preventing Staphylococcus aureus infection in the renal unit. QJM. 2002;95:405-10.
8. Bearman GM, Wenzel RP. Bacteremias: a leading cause of death. Arch Med Res. 2005;36:646-59.
9. Benfield T, Espersen F, Frimodt-Moller N, Jensen AG, Larsen AR, Pallesen LV, et al. Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infec. 2007;13:257-63.
10. Frimodt-Moller N, Espersen F, Skinhoj P, Rosdahl VT. Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990. Clin Microbiol Infect. 1997;3:297-305.
11. Sexton DJ. Vascular access infections in patients undergoing dialysis with special emphasis on the role and treatment of Staphylococcus aureus. Infect Dis Clin N Am. 2001;15:731-42.
12. Jensen AG, Wachmann CH, Espersen F, Scheibel J, Skinhoj P, Frimodt-Moller N. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med. 2002;162:25-32.
13. Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest. 2001;120:1883-7.
14. Prezant DJ. Effect of uremia and its treatment on pulmonary function. Lung. 1990;168:1-14.
15. Snyder JJ, Israni AK, Peng Y, Zhang L, Simon TA, Kasiske BL. Rates of first infection following kidney transplant in the United States. Kidney Int. 2009;75:317-26.
16. Registry DN. Danish Nephrology Registry, Annual Report 2010. 2010.
17. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System: a cohort of eight million persons. Dan Med Bull. 2006;53:441-9.
18. Henrik TSTC, Hanne KS, Lars P, editors. Use of Medical Databases in Clinical Epidemiology. 2009.
19. Larsen MV, Harboe ZB, Ladelund S, Skov R, Gerstoft J, Pedersen C, et al. Major but differential decline in the incidence of Staphylococcus aureus bacteraemia in HIV-infected individuals from 1995 to 2007: a nationwide cohort study*. HIV Med. 2012;13:45-53.
20. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol. 2003;56:221-9.
21. Muerkoster S, Wachowski O, Zerban H, Schirrmacher V, Umansky V, Rocha M. Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages. Clin Cancer Res. 1998;4:3095-106.
22. Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, et al. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med. 2013;173:1970-8.
23. Laupland KB, Lyytikainen O, Sogaard M, Kennedy KJ, Knudsen JD, Ostergaard C, et al. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect. 2013;19:465-71.
24. Kaech C, Elzi L, Sendi P, Frei R, Laifer G, Bassetti S, et al. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect. 2006;12:345-52.
25. del Rio A, Cervera C, Moreno A, Moreillon P, Miro JM. Patients at risk of complications of Staphylococcus aureus bloodstream infection. Clin Infect Dis. 2009;48 Suppl 4:S246-53.
26. AM Hammerum LS-R, SS Olsen, KG Kuhn, M Torpdahl, EM Nielsen, AR Larsen, A Petersen, RL Skov, Afdeling for Mikrobiologi og Infektionskontrol, M Laursen Afdeling for Dataleverancer og Lægemiddelstatistik. DANMAP 2012: Antibiotikaforbrug og -resistens. EPI- NYT. 2013;43.